Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Piper Sandler Maintains Underweight on BancFirst, Lowers Price Target to $84

Piper Sandler analyst Nathan Race maintains BancFirst (NASDAQ:BANF) with a Underweight and lowers the price target from $97 to $84.
byBenzinga Newsdesk
January 23, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Piper Sandler analyst Nathan Race maintains BancFirst (NASDAQ:BANF) with a Underweight and lowers the price target from $97 to $84.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

U.S. FDA Approves Bristol Myers Squibb And 2seventy bio’s Abecma For Triple-Class Exposed Relapsed Or Refractory Multiple Myeloma After Two Prior Lines Of Therapy; Abecma Tripled Progression-Free Survival Compared To Standard Regimens In The Phase 3 Ka…

By Benzinga Newsdesk
April 5, 9:07 AM
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial, with a 51% reduction in risk of disease progression or death and a well-established safety profileExpanded approval

BMY